Varicella-zoster virus (chickenpox) infection in pregnancy

  • Ronald F. Lamont*
  • , Jack D. Sobel
  • , D. Carrington
  • , Shali Mazaki-Tovi
  • , Juan Pedro Kusanovic
  • , Edi Vaisbuch
  • , Roberto Romero
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

161 Scopus citations

Abstract

Congenital varicella syndrome, maternal varicella-zoster virus pneumonia and neonatal varicella infection are associated with serious fetomaternal morbidity and, not infrequently, mortality. Vaccination against varicella-zoster virus can prevent the disease, and outbreak control limits the exposure of pregnant women to the infectious agent. Maternal varicella-zoster immunoglobulin administration before rash development, with or without antiviral medication, can modify the progression of the disease.

Original languageEnglish
Pages (from-to)1155-1162
Number of pages8
JournalBJOG: An International Journal of Obstetrics and Gynaecology
Volume118
Issue number10
DOIs
StatePublished - Sep 2011
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Chickenpox
  • infection
  • pregnancy
  • varicella
  • virus
  • zoster

Fingerprint

Dive into the research topics of 'Varicella-zoster virus (chickenpox) infection in pregnancy'. Together they form a unique fingerprint.

Cite this